These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 35721429)
1. Rhino-orbito-cerebral mucormycosis: an epidemic in a pandemic. Sekaran A; Patil N; Sabhapandit S; Sistla SK; Reddy DN IJID Reg; 2022 Mar; 2():99-106. PubMed ID: 35721429 [TBL] [Abstract][Full Text] [Related]
2. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y; Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034 [TBL] [Abstract][Full Text] [Related]
3. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India. Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435 [TBL] [Abstract][Full Text] [Related]
4. Spectrum of orbital fat necrosis in rhino-orbital-cerebral mucormycosis in post-COVID-19 patients. Agrawal A; Diwaker P; Dixit S; Rohatgi J; Arora VK Indian J Ophthalmol; 2024 Oct; 72(10):1478-1482. PubMed ID: 39331438 [TBL] [Abstract][Full Text] [Related]
5. Rhino orbital cerebral mucormycosis in settings of COVID-19 infection: A case series of thirteen patients. Verma R; Chakraborty R; Keerthiraj DB; Pal US Natl J Maxillofac Surg; 2023; 14(2):311-316. PubMed ID: 37661985 [TBL] [Abstract][Full Text] [Related]
6. Post-COVID-19 rhino-orbito-cerebral mucormycosis: a new addition to challenges in pandemic control. Mitra S; Janweja M; Sengupta A Eur Arch Otorhinolaryngol; 2022 May; 279(5):2417-2422. PubMed ID: 34309754 [TBL] [Abstract][Full Text] [Related]
7. Sinonasal and Orbital Imaging Findings in COVID-Associated Rhino-Orbito-Cerebral Mucormycosis During the Second Wave of COVID-19: A Retrospective Cohort Study in a Tertiary Hospital in Central India. B H S; Kumbhalkar S; Selvi K; G D; Bidkar V; Dabhekar S; Prathipati K; Sawal A Cureus; 2023 Jul; 15(7):e42674. PubMed ID: 37649953 [TBL] [Abstract][Full Text] [Related]
8. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially. Jiang N; Zhao G; Yang S; Lin J; Hu L; Che C; Wang Q; Xu Q BMC Ophthalmol; 2016 Jan; 16():10. PubMed ID: 26758904 [TBL] [Abstract][Full Text] [Related]
9. Hit or Miss: The Dilemma of Specimen Selection for Microbiological Diagnosis of Rhino-Orbital-Cerebral- COVID-Associated Mucormycosis (ROCM-CAM). Jain V; Aggarwal A; Shrimali T; Vishwakarma K; Paul D; Kombade SP; Sharma V; Soni K; Choudhary B; Goyal A; Chugh A; Tiwari S; Sharma DK; Agarwal A; Misra S Infect Disord Drug Targets; 2023; 23(1):e160822207524. PubMed ID: 35975857 [TBL] [Abstract][Full Text] [Related]
10. Mortality and its determinants after an outbreak of post COVID-19 associated rhino-orbito-cerebral mucormycosis in Central India. Nagarkar NM; Sahu V; Arora R; Pathak M; Shambharkar MS; Naveen P Int Ophthalmol; 2023 Jul; 43(7):2363-2370. PubMed ID: 36645635 [TBL] [Abstract][Full Text] [Related]
11. Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review. Karkhur S; Soni D; Chauhan K; Sarkar D; Gautam M; Verma S; Nyodu R; Yadav N; Sharma B Indian J Ophthalmol; 2023 Jan; 71(1):39-56. PubMed ID: 36588206 [TBL] [Abstract][Full Text] [Related]
12. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus. Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273 [TBL] [Abstract][Full Text] [Related]
13. Ophthalmic presentation and outcomes of rhino-orbito-cerebral mucormycosis during the COVID-19 pandemic: An 18-month follow-up report. Veisi A; Aletaha M; Abolhosseini M; Ownagh V; Fekri S; Feizi M; Amoushahi Khouzani S; Najafi M J Fr Ophtalmol; 2024 Mar; 47(5):104139. PubMed ID: 38696866 [TBL] [Abstract][Full Text] [Related]
14. Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience. Soni K; Das A; Sharma V; Goyal A; Choudhury B; Chugh A; Kumar D; Yadav T; Jain V; Agarwal A; Garg M; Bhatnagar K; Elhence P; Bhatia PK; Garg MK; Misra S J Mycol Med; 2022 May; 32(2):101238. PubMed ID: 34979299 [TBL] [Abstract][Full Text] [Related]
15. Clinicoradiological profile and outcome of cavernous sinus syndrome with coronavirus disease-2019-associated rhino-orbito-cerebral mucormycosis. Sulena S; Dhawan M; Singh N; Arora H; Singh G; Aggarwal V; Tapasvi C J Neurosci Rural Pract; 2022; 13(4):730-739. PubMed ID: 36743739 [TBL] [Abstract][Full Text] [Related]
16. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India. Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004 [TBL] [Abstract][Full Text] [Related]